New Delhi: India could join the 26 countries to approve Russia’s Sputnik V COVID-19 vaccine in the next few weeks, RIA news agency cited India’s ambassador to Moscow as saying on Monday.
The trials of the vaccine have been started in small batches by India’s Dr. Reddy’s Laboratories Ltd. The lab had earlier stated that Sputnik V meets the primary safety requirements for phase-2 clinical trials in India.
The mid-stage trial data have been submitted to the drug regulator.
The Lancet medical journal stated that the Russian vaccine is more effective than the Chinese ones, and it has 91.6 per cent success rate.
The Sputnik V can be stored in a fridge unlike Pfizer and Moderna’s vaccines.
In September 2020, Dr. Reddy’s and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct its clinical trials.
Also Read: First Trial: Oxford COVID-19 Vaccine To Be Tested On Children
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.